|
Oct 16
|
Is Cytokinetics Inc. (CYTK) the Most Promising Biotech Stock According to Hedge Funds?
|
|
Oct 16
|
Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day
|
|
Oct 2
|
Cytokinetics to Host Investor & Analyst Day on October 16, 2024
|
|
Oct 1
|
Is Cytokinetics Inc. (CYTK) Positioned for Success with Its Innovative Muscle Modulators?
|
|
Sep 30
|
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
|
|
Sep 27
|
Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
|
|
Jul 30
|
Investors in Cytokinetics (NASDAQ:CYTK) have seen incredible returns of 381% over the past five years
|
|
Jul 30
|
Cytokinetics Announces Call for Proposals for Corporate Giving Program
|
|
Jul 25
|
Cytokinetics to Announce Second Quarter Results on August 8, 2024
|
|
Jul 25
|
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jul 23
|
Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
|
|
Jun 12
|
Insider Sale at Cytokinetics Inc (CYTK) by EVP of Research & Development
|
|
Jun 10
|
Insider Sale: Director Muna Bhanji Sells Shares of Cytokinetics Inc (CYTK)
|
|
Jun 5
|
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
|
|
Jun 5
|
Insider Sale: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
|
|
May 29
|
Cytokinetics to Participate in June Investor Conferences
|
|
May 28
|
Cytokinetics Announces Closing of Public Offering of Common Stock
|
|
May 27
|
Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now?
|
|
May 24
|
Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
|
|
May 23
|
Cytokinetics secures up to $575M in royalty deal, frustrating investors
|